Showing results (151-160 of 719) with videos related to
Sort By:
Pageof 72
Letters in Applied Microbiology|March 31, 2021
Comparison of novel approaches for expedited pathogen identification and antimicrobial susceptibility testing against routine blood culture diagnosticsL Knabl, S Huber, C Lass-Flörl, et al.Psychiatry Research|November 10, 2019
A qualitative systematic review of suicide behavior using the cognitive systems domain of the research domain criteria (RDoC) frameworkRebekah S Huber, Riley Hodgson, Deborah A Yurgelun-ToddClinical Orthopaedics and Related Research|June 13, 2001
Limb salvage surgery with vascular reconstructionR E Leggon, T S Huber, M T ScarboroughNeuromodulation : Journal of the International Neuromodulation Society|December 14, 2011
Spinal cord stimulation in severe, inoperable peripheral vascular diseaseS J Huber, R M Vaglienti, J S HuberJournal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|July 13, 2006
The role of complement, C5a and its receptors in sepsis and multiorgan dysfunction syndromeMichael A Flierl, Heike Schreiber, Markus S Huber-LangPsychological Research|August 28, 2010
Two-digit number processing: holistic, decomposed or hybrid? A computational modelling approachK Moeller, S Huber, H-C Nuerk, et al.Bio-Medical Materials and Engineering|April 5, 2017
Transforming growth factor-beta 1 or ascorbic acid are able to differentiate Wharton's jelly mesenchymal stem cells towards a smooth muscle phenotypeB Mesure, S Huber-Villaume, P Menu, et al.Schweizer Archiv Fur Tierheilkunde|May 6, 2020
[Improvement of claw health of cattle in Switzerland]S Huber, M Welham Ruiters, C Syring, et al.The Journal of Clinical Investigation|February 1, 1993
Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patientsA Valli, A Sette, L Kappos, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|December 24, 2009
Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year resultsG Comi, P O'Connor, X Montalban, et al.Pageof 72